Gilead Sciences, Inc [GILD] stock prices are up 1.06% to $114.23 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GILD shares have gain 3.69% over the last week, with a monthly amount glided 3.22%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Gilead Sciences, Inc [NASDAQ: GILD] stock has seen the most recent analyst activity on July 25, 2025, when Needham upgraded its rating to a Buy but kept the price target unchanged to $133 for it. On March 04, 2025, Oppenheimer reiterated its Outperform rating and revised its price target to $132 on the stock. Deutsche Bank upgraded its rating to a Buy but stick to its price target of $120 on February 18, 2025. DZ Bank upgraded its rating to a Buy but $108 remained the price target by the analyst firm on February 13, 2025. Morgan Stanley upgraded its rating to Overweight for this stock on January 10, 2025, and upped its price target to $113.
The stock price of Gilead Sciences, Inc [GILD] has been fluctuating between $72.43 and $119.96 over the past year. Currently, Wall Street analysts expect the stock to reach $126.4 within the next 12 months. Gilead Sciences, Inc [NASDAQ: GILD] shares were valued at $114.23 at the most recent close of the market. An investor can expect a potential return of 10.65% based on the average GILD price forecast.
Analyzing the GILD fundamentals
The Gilead Sciences, Inc [NASDAQ:GILD] reported sales of 28.69B for trailing twelve months, representing a drop of -0.60%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.24%, and Net Profit Margin reading is 0.21%. To continue investigating profitability, this company’s Return on Assets is posted at 0.11, Equity is 0.32 and Total Capital is 0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 112.89 points at the first support level, and at 111.54 for the second support level. However, for the 1st resistance point, the stock is sitting at 114.99, and for the 2nd resistance point, it is at 115.75.
Ratios To Look Out For
It’s worth pointing out that Gilead Sciences, Inc [NASDAQ:GILD]’s Current Ratio is 1.37. Further, the Quick Ratio stands at 1.23, while the Cash Ratio is 0.64. Considering the valuation of this stock, the price to sales ratio is 4.95, the price to book ratio is 7.42 and price to earnings (TTM) ratio is 24.02.
Transactions by insiders
Recent insider trading involved O’Day Daniel Patrick, Chairman & CEO, that happened on Jul 28 ’25 when 10000.0 shares were sold. Officer, DANIEL ODAY completed a deal on Jul 28 ’25 to buy 10000.0 shares. Meanwhile, Chief Commercial Officer Mercier Johanna sold 3000.0 shares on Jul 15 ’25.
